Beryl Drugs Ltd. BSE: 524606

Download real time

22.20 -1.05 (-4.52%)

48.37% Fall from 52W High

787

BSE Volume

BSE 05 Jan, 2026 3:31 PM (IST)

Beryl Drugs Corporate Filings & Announcements

Latest corporate announcements and filings from Beryl Drugs on BSE

Search Inside the pdf :

Beryl Drugs Ltd.

05 Jan 2026, 07:24PM

22.20

-4.52%

Company Update

Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

CONSIDERATION OF APPOINTMENT OF MRS. NEHA SARDA AS INDEPENDENT DIRECTOR OF THE COMPANY SUBJECT TO THE APPROVAL OF SHAREHOLDERS IN GENERAL MEETING

Beryl Drugs Ltd.

05 Jan 2026, 07:22PM

22.20

-4.52%

Company Update

Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

APPOINTMENT OF MR SHAILENDRA PATHAK AS AN ADDITIONAL DIRECTOR SUBJECT TO APPROVAL OF SHAREHOLDERS

Beryl Drugs Ltd.

05 Jan 2026, 07:18PM

22.20

-4.52%

Company Update

Beryl Drugs Ltd - 524606 - Appointment of Company Secretary and Compliance Officer

BSE India

APPOINTMENT OF MR. KAMLESH GUPTA AS COMPANY SECRETARY AND COMPLIANCE OFFICER OF THE COMPANY

Beryl Drugs Ltd.

05 Jan 2026, 07:15PM

22.20

-4.52%

Company Update

Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Cessation

BSE India

RESIGNATION OF MRS. NEHA SHARMA, COMPANY SECRETARY OF THE COMPANY W.E.F 3RD JANUARY, 2026

Beryl Drugs Ltd.

03 Jan 2026

22.20

-4.52%

Board Meeting

Beryl Drugs Ltd - 524606 - Board Meeting Outcome for OUTCOME OF BOARD MEETING

BSE India

OUTCOME OF BOARD MEETING

Beryl Drugs Ltd.

31 Dec 2025

22.20

-4.52%

SAST

Beryl Drugs Ltd - 524606 - Closure of Trading Window

BSE India

Closure of trading window for the quarter ended 31.12.2025

Beryl Drugs Ltd.

23 Dec 2025

22.20

-4.52%

Board Meeting

Beryl Drugs Ltd - 524606 - Board Meeting Intimation for INTIMATION OF 5/2025-2026 BOARD MEETING

BSE India

Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/01/2026 ,inter alia, to consider and approve 1. To consider and approve the Appointment of Shailendra Pathak as an Additional Director subject to approval of shareholders in general meeting. 2. To consider and approve the Appointment of Mrs. Neha Sharda as an Independent Director subject to approval of shareholders in general meeting. 3. To consider and approve related party transaction with Aminova Infusions P. Ltd. subject to approval of shareholders in general meeting. 4. To consider and approve the resignation of Mrs. Neha Sharma from post of Company Secretary. 5. To consider and approve appointment of Mr. Kamlesh Gupta as the Company Secretary. 6. To consider and approve the date of holding EOGM. 7. Any other matter with the permission of the Chair.

Beryl Drugs Ltd.

15 Nov 2025

22.20

-4.52%

Company Update

Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

results publication for quarter/ half year ended 30.09.2025

Beryl Drugs Ltd.

13 Nov 2025

22.20

-4.52%

Result

Beryl Drugs Ltd - 524606 - UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH SEPTEMBER, 2025

BSE India

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH SEPTEMBER, 2025

Beryl Drugs Ltd.

13 Nov 2025

22.20

-4.52%

Board Meeting

Beryl Drugs Ltd - 524606 - Board Meeting Outcome for OUTCOME OF BOARD MEETING

BSE India

OUTCOME OF BOARD MEETING

Is Beryl Drugs Ltd. worth buying?

10 Votes:

Buy 60.0%

Sell 30.0%

Hold 10.0%